Henry Schein, Inc. (HSIC) Stock Price: $78.67-1.25 (-1.56%)
At close: Jun 22, 2026, 4:00 PM ET
The closing share price for Henry Schein, Inc. (HSIC) stock was $78.67 for Monday, June 22, 2026, down 1.56% on the day.
Longer view (total return, dividends reinvested): past 12 months +9.3% · 3-year avg -0.4%/yr · 5-year avg +0.6%/yr
HSIC Price Chart
HSIC Key Metrics
See All MetricsLAST CLOSE PRICE
$78.67
52-WEEK RANGE
$61.95 - $89.29
BETA
0.82
% FROM 52W HIGH
-11.89%
MARKET CAP
$8.96B
DIVIDEND YIELD
N/A
PE RATIO
trailing TTM
23.77
PE RATIO (FWD)
next-FY estimate
14.71
P/B RATIO
2.80
DEBT / EQUITY
1.14
REVENUE TTM
$13.38B
NET INCOME TTM
$395.00M
NET PROFIT MARGIN TTM
2.95%
TTM TOTAL RETURN
+9.25%
3Y TOTAL RETURN
-0.44%
5Y TOTAL RETURN
+0.58%
HSIC Earnings Preview
Next Earnings Date
Aug 4, 2026
42 days away
EPS Estimate
1.20
Revenue Est.
$3.38B
Last Quarter Results
EPS
$1.32
vs Estimate
$1.22
Revenue
$3.37B
vs Estimate
$3.34B
HSIC Analyst Ratings
Consensus Rating
Based on 15 analysts
Average Price Target
$88.07
+11.9% upside
Low
$64.00
Current
$78.67
High
$100.00
HSIC Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $1.42 | $1.44 | $1.45 | 4 |
| Q2 2027 | $1.36 | $1.37 | $1.39 | 4 |
| Q3 2027 | $1.49 | $1.51 | $1.53 | 6 |
| Q4 2027 | $1.56 | $1.57 | $1.59 | 9 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $5.28 | $5.35 | $5.38 | 10 |
| FY 2027 | $5.83 | $5.92 | $6.13 | 10 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $3.47B | $3.49B | $3.53B | 8 |
| Q2 2027 | $3.47B | $3.50B | $3.53B | 8 |
| Q3 2027 | $3.57B | $3.59B | $3.63B | 8 |
| Q4 2027 | $3.68B | $3.70B | $3.74B | 8 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $13.71B | $13.75B | $13.80B | 12 |
| FY 2027 | $14.21B | $14.26B | $14.35B | 12 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
HealthcareHSIC Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HSIC | $8.96B | $78.67 | -1.56% | +9.25% | +0.58% | +1.38% | — |
| 2CRL | $8.75B | $181.56 | -1.86% | +23.01% | -12.99% | +8.10% | vs HSIC |
| 3TEM | $8.35B | $47.85 | -5.88% | -29.83% | N/A | N/A | vs HSIC |
| 4BAX | $10.15B | $19.66 | -1.16% | -33.76% | -23.18% | -6.49% | vs HSIC |
| 5OSCR | $7.63B | $28.54 | +0.49% | +43.69% | +4.67% | N/A | vs HSIC |
| 6BIO | $7.60B | $281.11 | -0.47% | +18.64% | -14.77% | +7.08% | vs HSIC |
HSIC Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini